News

Innovative Collaboration Between epiq Animal Health and Zesty Paws

Innovative Collaboration Between epiq Animal Health and Zesty Paws

Revolutionary Partnership in Animal Health Products

In an exciting development for pet health enthusiasts, epiq Animal Health and Zesty Paws have forged a strategic partnership aimed at enhancing the veterinary-only product market. This collaboration brings together two influential names in the pet health industry, both known for their dedication to improving the lives of pets and their owners.

Introducing Zesty Paws Professional™ Native Probiotic Line

As a trusted brand recognized for quality pet supplements, Zesty Paws is expanding its offerings with the introduction of the Zesty Paws Professional™ Native Probiotic line. This marks Zesty Paws' inaugural venture into the veterinary channel, showcasing a product line specifically tailored for the health needs of canines. These innovative probiotics are formulated using strains sourced directly from the gut of healthy dogs, ensuring maximum efficacy in addressing digestive health.

Addressing Health Needs with Science-backed Solutions

The Professional Native Probiotic line features two distinct products: one aimed at therapeutic use and the other focused on digestive health maintenance. Notably, the introduction of these products emphasizes a rigorous scientific approach, warranting their development through collaboration with microbiome experts and veterinary professionals. This meticulous groundwork aligns with Zesty Paws' commitment to delivering reliable and effective health solutions for pets.

Growth Opportunities through Collaboration

Akash Bedi, CEO for North America, the Middle East, and India at H&H Group, underscored the significance of this partnership by stating that it plays a critical role in Zesty Paws' growth strategy. By teaming up with epiq Animal Health, Zesty Paws is poised to access new channels for distributing innovative health solutions that are clinically relevant for veterinary professionals across the country.

Empowering Veterinary Professionals

Both companies share a vision of developing effective supply chain solutions while also focusing on educating veterinary communities. The aim is to facilitate the adoption of these pioneering products among veterinary professionals, creating a positive impact on canine digestive health. Through this initiative, they aspire to raise awareness and provide tools that can elevate pet care standards.

Mission-Driven Approaches in Animal Health

At the heart of these efforts lies epiq Animal Health’s mission to collaborate with manufacturers and distributors in the animal health sector. Their goal is to ensure that industry-leading products are readily available to veterinary professionals and pet owners alike. Partnering with a reputable brand like Zesty Paws is a significant step towards achieving this objective.

About epiq Animal Health

epiq Animal Health is a notable solutions provider and valued distributor that specializes in the animal health industry. Known for creating efficiencies in the supply chain, they focus on product management and strategic partnerships to optimize market success. By combining industry insights with robust relationships, epiq strives to find successful pathways in diverse distribution channels.

About Zesty Paws

Zesty Paws epitomizes a dedicated commitment to pet wellness, striving for excellence in every product they offer. The company’s philosophy of being "wellness nerds" reflects their thorough research and passion for pet health. Their unique approach, encapsulated in their mantra "Bite-Sized. Pet Science.™," ensures that all products are scientifically backed and designed to assist pets in living vibrant, healthy lives. Additionally, Zesty Paws is proud to have received the NASC Quality Seal, affirming their commitment to quality standards in the supplement industry.

Frequently Asked Questions

What is the purpose of the partnership between epiq Animal Health and Zesty Paws?

The collaboration aims to enhance the availability of veterinary-only products, particularly the new Zesty Paws Professional™ Native Probiotic line, to support the health of dogs.

What are the key features of the Zesty Paws Professional™ Native Probiotic line?

This product line is formulated with canine-native probiotic strains sourced from healthy dogs and includes products focused on therapeutic use and digestive health maintenance.

How do epiq Animal Health and Zesty Paws plan to promote their products?

They aim to educate and train veterinary professionals to incorporate these products into their practices effectively.

What does epiq Animal Health specialize in?

epiq Animal Health specializes in providing distribution solutions, product management, and strategic partnerships in the animal health industry.

How does Zesty Paws ensure the quality of its products?

Zesty Paws conducts thorough research and works with microbiome scientists and veterinarians to develop effective and safe pet health solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 87

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 119

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 177

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 38

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 104

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 198

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading

Top 5 Most Recently Viewed Articles

MiMedx Group Q4 Earnings: Impressive Beat Raises Eyebrows

Updated Category News Views 262

What a Turnaround! Numbers don’t lie, right? Well, take a look at MiMedx Group (NASDAQ:MDXG) and you see a company that’s done some real transformation. Their Q4 report came out on February 25, 2026, and it’s hard not to be impressed. They smashed the earnings estimate—by a whopping 40%. That’s no small feat in this market, especially when you look at the EPS...

Continue Reading
Intuitive Machines Sets Financial Results Conference Call Date

Updated Category News Views 132

Intuitive Machines Schedules Conference Call for Financial Results Intuitive Machines, Inc. (Nasdaq: LUNR) has made an important announcement regarding its upcoming financial results. The company is set to release its fourth quarter and full-year financial outcomes, providing an in-depth look at its performance for 2024. This announcement will be made on a specific date...

Continue Reading
OSB Group PLC: Insights into the Latest Block Listing Return

Updated Category News Views 326

Understanding OSB Group PLC's Block Listing Return In the ever-evolving landscape of financial markets, regular disclosures play a pivotal role in maintaining transparency. Here, we delve into the latest block listing return from OSB Group PLC, outlining crucial details in a clear and concise manner. Key Details of the Block Listing Return It's essential for stakeholders...

Continue Reading
Gemini Expands its Offerings with Tokenized U.S. Equities

Updated Category News Views 342

Gemini Launches Tokenized U.S. Equities In an exciting development for European investors, Gemini has expanded its offerings by facilitating the trading of tokenized U.S. equities. This marks a significant shift in providing easier access to international investment opportunities. Initially launched for its user base in Europe, Gemini aims to create a seamless experience...

Continue Reading
Vivian Health Welcomes New CEO Bill Kong for Future Growth

Updated Category News Views 125

Vivian Health's New Era with CEO Bill Kong Vivian Health, a prominent player in the healthcare jobs marketplace, is transitioning into a new chapter under the leadership of Bill Kong, who has been appointed as the CEO. This strategic move follows the remarkable success achieved by Parth Bhakta, co-founder and outgoing CEO, who now assumes the role of Executive Chairman....

Continue Reading